[(4-Hydroxyl-benzo[4,5]thieno[3,2-c]pyridine-3-carbonyl)-amino]-acetic acid derivatives; HIF prolyl 4-hydroxylase inhibitors as oral erythropoietin secretagogues.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Bioorganic & Medicinal Chemistry Letters

• Publication date

  2013-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bmcl.2013.08.067PMID 24042008
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypoxia-inducible factor stabilizers and other small-molecule erythropoiesis-stimulating agents in current and preventive doping analysis.

  2012cited by this paper
• Prolyl Hydroxylase Domain Inhibitors: A Route to HIF Activation and Neuroprotection

  2010cited by this paper
• Inhibition of oxygen sensors as a therapeutic strategy for ischaemic and inflammatory disease

  2009cited by this paper
• Biology of hypoxia-inducible factor-2α in development and disease

  2008cited by this paper
• Mucosal protection by hypoxia‐inducible factor (HIF) prolyl hydroxylase inhibition

  2008cited by this paper
• Biology of HIF-1α

  2008cited by this paper
• Mucosal protection by hypoxia-inducible factor prolyl hydroxylase inhibition.

  2008cited by this paper
• HIF prolyl hydroxylase inhibition results in endogenous erythropoietin induction, erythrocytosis, and modest fetal hemoglobin expression in rhesus macaques.

  2007cited by this paper
• Hypoxia, drug therapy and toxicity.

  2007cited by this paper
• Cellular oxygen sensing: Crystal structure of hypoxia-inducible factor prolyl hydroxylase (PHD2).

  2006cited by this paper
• HYPOXIA‐INDUCED ERYTHROPOIETIN PRODUCTION: A PARADIGM FOR OXYGEN‐REGULATED GENE EXPRESSION

  2006cited by this paper
• Novel strategies for stimulating erythropoiesis and potential new treatments for anaemia.

  2006cited by this paper
• A fluorescence polarization-based interaction assay for hypoxia-inducible factor prolyl hydroxylases.

  2005cited by this paper
• Targeting hypoxia-inducible factor (HIF) as a therapeutic strategy for CNS disorders.

  2005cited by this paper
• HIF-1 as a target for drug development

  2003cited by this paper
• Biochemical purification and pharmacological inhibition of a mammalian prolyl hydroxylase acting on hypoxia-inducible factor

  2002cited by this paper
• Comparison of murine Epo ELISA and Epo bioassays in detecting serum Epo levels during anemia associated with malaria infection.

  2002cited by this paper
• HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus.

  2001cited by this paper

• Evaluation of 2-(1H-1,2,3-triazol-1-yl) acetic acid derivatives as potential human hypoxia-inducible factor (HIF) prolyl hydroxylase domain-2 (PHD2) inhibitors

  2025cites this paper
• Recent advancements in the synthesis of fused thienopyridines and their therapeutic applications

  2024cites this paper
• Safety of HIF prolyl hydroxylase inhibitors for anemia in dialysis patients: a systematic review and network meta-analysis

  2023cites this paper
• Efficacy and Safety of Daprodustat for Anemia Therapy in Chronic Kidney Disease Patients: A Systematic Review and Meta-Analysis

  2021cites this paper
• Inhibition of AlkB Nucleic Acid Demethylases: Promising New Epigenetic Targets.

  2021cites this paper
• Local Stabilization of Hypoxia-Inducible Factor-1α Controls Intestinal Inflammation via Enhanced Gut Barrier Function and Immune Regulation

  2021cites this paper
• Immune and Stromal Signature-Based Prognostic Gene of Bladder Cancer

  2020cites this paper
• Effects of sorbitol and lactate on erythropoietin production in HepG2 cells.

  2019cites this paper
• Hypoxia Inducible Factor-1α in Osteochondral Tissue Engineering

  2019cites this paper
• Harnessing HIF-1α for osteochondral tissue engineering

  2019cites this paper
• Furan- and Thiophene-2-Carbonyl Amino Acid Derivatives Activate Hypoxia-Inducible Factor via Inhibition of Factor Inhibiting Hypoxia-Inducible Factor-1

  2018cites this paper
• Triterpenoid Hydroxamates as HIF Prolyl Hydrolase Inhibitors.

  2018cites this paper
• CRISPR-Mediated Tagging of Endogenous Proteins with a Luminescent Peptide.

  2017cites this paper
• Discovery of N-[Bis(4-methoxyphenyl)methyl]-4-hydroxy-2-(pyridazin-3-yl)pyrimidine-5-carboxamide (MK-8617), an Orally Active Pan-Inhibitor of Hypoxia-Inducible Factor Prolyl Hydroxylase 1-3 (HIF PHD1-3) for the Treatment of Anemia.

  2016cites this paper
• Hypoxia enhances tenocyte differentiation of adipose‐derived mesenchymal stem cells by inducing hypoxia‐inducible factor‐1α in a co‐culture system

  2016cites this paper
• Anaemia in kidney disease: harnessing hypoxia responses for therapy

  2015cites this paper
• Stimulating Effect of Ethanol on Erythropoietin Production in the Liver Cells

  2014cites this paper